Production of Free Fatty Acids From Blood Triglycerides
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00911482 |
Recruitment Status :
Completed
First Posted : June 2, 2009
Last Update Posted : November 7, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Diabetes Mellitus, Type 2 Insulin Resistance Dyslipidemias |
Study Type : | Observational |
Actual Enrollment : | 16 participants |
Time Perspective: | Cross-Sectional |
Official Title: | FFA Production From Triglyceride-Rich Lipoproteins |
Study Start Date : | June 2008 |
Actual Primary Completion Date : | January 2012 |
Actual Study Completion Date : | January 2012 |
Group/Cohort |
---|
Diabetes/weight loss
12 individuals with type 2 diabetes and hypertriglyceridemia
|
Nondiabetic/hypertriglyceridemic
10 insulin resistant nondiabetic individuals with dyslipidemia
|
Normotensive/nondiabetic
10 insulin resistant, normotensive, nondiabetic individuals
|
Insulin resistant/dyslipidemic
14 insulin resistant nondiabetic individuals with dyslipidemia
|
- Spillover of free fatty acids from chylomicrons [ Time Frame: Measured at 1 to 6 days ]
Biospecimen Retention: Samples Without DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 35 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Type 2 diabetes
- Atherogenic dyslipidemia
- Obesity
Exclusion Criteria:
- Kidney disease
- Liver disease
- Coronary artery disease
- Retinopathy
- Neuropathy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00911482
United States, Minnesota | |
Mayo Clinic | |
Rochester, Minnesota, United States, 55905 |
Principal Investigator: | John M. Miles, MD | Mayo Clinic |
Responsible Party: | John M. Miles, MD, Mayo Foundation |
ClinicalTrials.gov Identifier: | NCT00911482 |
Other Study ID Numbers: |
08-001493 R01HL067933 ( U.S. NIH Grant/Contract ) |
First Posted: | June 2, 2009 Key Record Dates |
Last Update Posted: | November 7, 2012 |
Last Verified: | November 2012 |
Type 2 Diabetes Dyslipidemia FFA Triglycerides Tracers |
Diabetes Mellitus, Type 2 Insulin Resistance Dyslipidemias Diabetes Mellitus Glucose Metabolism Disorders |
Metabolic Diseases Endocrine System Diseases Hyperinsulinism Lipid Metabolism Disorders |